BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23782002)

  • 1. Feline sarcoptic mange in Taiwan: a case series of five cats.
    Huang HP; Lien YH
    Vet Dermatol; 2013 Aug; 24(4):457-9, e104-5. PubMed ID: 23782002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline sarcoptic mange in Poland: A case series of three cats.
    Szczepanik M; Wilkolek P; Kalisz G; Szczepaniak K
    Vet Med Sci; 2024 Jul; 10(4):e1500. PubMed ID: 38864312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crusted scabies (sarcoptic mange) in four cats due to Sarcoptes scabiei infestation.
    Malik R; McKellar Stewart K; Sousa CA; Krockenberger MB; Pope S; Ihrke P; Beatty J; Barrs VR; Walton S
    J Feline Med Surg; 2006 Oct; 8(5):327-39. PubMed ID: 16950639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
    Krieger K; Heine J; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Treatment of Demodex gatoi with 10% Imidacloprid/1% Moxidectin.
    Short J; Gram D
    J Am Anim Hosp Assoc; 2016; 52(1):68-72. PubMed ID: 26606209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of naturally Notoedres cati-infested cats with a combination of imidacloprid 10 % / moxidectin 1 % Spot-on (Advocate® / Advantage® Multi, Bayer).
    Hellmann K; Petry G; Capari B; Cvejic D; Krämer F
    Parasitol Res; 2013 Aug; 112 Suppl 1():57-66. PubMed ID: 23760872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and duration of action of oral fluralaner and spot-on moxidectin/imidacloprid in cats infested with Lynxacarus radovskyi.
    Han HS; Noli C; Cena T
    Vet Dermatol; 2016 Dec; 27(6):474-e127. PubMed ID: 27870235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of an imidacloprid/moxidectin combination against naturally acquired Sarcoptes scabiei infestations on dogs.
    Fourie LJ; Heine J; Horak IG
    Aust Vet J; 2006; 84(1-2):17-21. PubMed ID: 16498829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.
    Becskei C; De Bock F; Illambas J; Cherni JA; Fourie JJ; Lane M; Mahabir SP; Six RH
    Vet Parasitol; 2016 May; 222():56-61. PubMed ID: 26928658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
    Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
    Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
    Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
    Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 1% spot-on against Otodectes cynotisin cats.
    Fourie LJ; Kok DJ; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S112-3. PubMed ID: 12928871
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of a spot-on formulation of pyriprole on dogs infested with Sarcoptes scabiei.
    Fourie JJ; Horak IG; de la Puente Redondo V
    Vet Rec; 2010 Sep; 167(12):442-5. PubMed ID: 20852247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.
    Colombo S; Leone F; Vercelli A; Cornegliani L
    Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs.
    Fourie LJ; Du Rand C; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S135-6. PubMed ID: 12928880
    [No Abstract]   [Full Text] [Related]  

  • 16. Field efficacy and safety of a combination of moxidectin and imidacloprid for the prevention of feline heartworm (Dirofilaria immitis) infection.
    Venco L; Mortarino M; Carro C; Genchi M; Pampurini F; Genchi C
    Vet Parasitol; 2008 Jun; 154(1-2):67-70. PubMed ID: 18395348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoptic mange in free-ranging pampas foxes in the Gran Chaco, Bolivia.
    Deem SL; Noss AJ; Cuéllar RL; Villarroel R; Linn MJ; Forrester DJ
    J Wildl Dis; 2002 Jul; 38(3):625-8. PubMed ID: 12238385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Larvicidal and persistent efficacy of an imidacloprid and moxidectin topical formulation against endoparasites in cats and dogs.
    von Samson-Himmelstjerna G; Epe C; Schimmel A; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S114-5. PubMed ID: 12928872
    [No Abstract]   [Full Text] [Related]  

  • 19. Sarcoptic mange in three alpacas treated successfully with amitraz.
    Lau P; Hill PB; Rybnícek J; Steel L
    Vet Dermatol; 2007 Aug; 18(4):272-7. PubMed ID: 17610494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of canine generalized demodicosis with a 'spot-on' formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate, Bayer Healthcare).
    Mueller RS; Meyer D; Bensignor E; Sauter-Louis C
    Vet Dermatol; 2009 Oct; 20(5-6):441-6. PubMed ID: 20178482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.